PNG version of QUB Shield - Red

NICR_Logo_215W_84H

2008

Boyle P, Anderson BO, Andersson LC, Gavin AT, et al. Need for global action for cancer control (Editorial). Annals of  Oncology, September 2008, doi: 10.1093/annonc/mdn426.

Cantwell MM, Forman MR, Middleton RJ, Murray LJ.  Association of early life factors and brain tumour risk in a cohort study. British Journal of Cancer, September 2008, doi:10.1038/sj.bjc.6604615.

Connolly D, Black A, Murray L, Nambirajan T, Keane PF, Gavin AT.  The utility of prostate – specific antigen velocity thresholds in clinical practice: a population – based analysis. British Journal of Urology International, June 2008, doi: 10.1111/j.1464-410X.2008.07470.x.

Gormley G, Connolly D, Catney DC, Freeman L, Murray L, Gavin AT. Reporting of research data by GP’s: a cautionary tale for primary care. Family Practice, June 2008, doi: 10.1093/fampra/cmn013.

Fleming I, Monaghan P, Gavin AT, O’Neill C. Factors influencing hospital costs of lung cancer patients in Northern Ireland. European Journal of Health Economics, February 2008, doi: 10.1007/s10198-007-0047-4 .

Connolly D, Black A, Gavin AT, Keane PF, Murray L.  Baseline prostate-specific-antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation.  Cancer Epidemiology Biomarkers and Prevention, February 2008, doi: 10.1158/1055-9965.EPI-07-0515.